Dennis Kannenkeril

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage.

Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage.

Journal: Cardiovascular diabetology

Published: April 27, 2026

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Journal: Frontiers in immunology

Published: April 02, 2026

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.

Journal: BMJ open

Published: February 26, 2026

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.

Journal: BMJ open

Published: February 26, 2026

Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure.

Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure.

Journal: European journal of heart failure

Published: July 11, 2025

Retinal capillary rarefaction is associated with the systemic immune-inflammatory index in patients with hypertension.

Retinal capillary rarefaction is associated with the systemic immune-inflammatory index in patients with hypertension.

Journal: Journal of hypertension

Published: June 05, 2025

Effect of renal denervation on the lipid profile in patients with or without coronary artery disease.

Effect of renal denervation on the lipid profile in patients with or without coronary artery disease.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: May 28, 2025

Effects of Combination Treatment on Renal Endothelial Function in Type 2 Diabetes Mellitus.

Effects of Combination Treatment on Renal Endothelial Function in Type 2 Diabetes Mellitus.

Journal: Kidney international reports

Published: April 29, 2025

A randomized, controlled, 12-month trial on the effects of an interdisciplinary treatment approach in ESRD patients: study protocol of the smart and fit for kidney transplantation trial (S&F4KTx).

A randomized, controlled, 12-month trial on the effects of an interdisciplinary treatment approach in ESRD patients: study protocol of the smart and fit for kidney transplantation trial (S&F4KTx).

Journal: Trials

Published: March 17, 2025

Endothelial function in high-risk patients with ezetimibe therapy.

Endothelial function in high-risk patients with ezetimibe therapy.

Journal: Journal of clinical lipidology

Published: March 09, 2025

Renal denervation is effective in reducing blood pressure in patients with CKD.

Renal denervation is effective in reducing blood pressure in patients with CKD.

Journal: Clinical kidney journal

Published: February 27, 2025

Renal denervation increases capillary density in hypertensive patients.

Renal denervation increases capillary density in hypertensive patients.

Journal: European journal of preventive cardiology

Published: February 02, 2025

Showing 1-12 of 57

Last Updated: 09/26/2026